Form 8-K - Current report:
SEC Accession No. 0001628280-24-052235
Filing Date
2024-12-20
Accepted
2024-12-20 16:31:25
Documents
15
Period of Report
2024-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blfs-20241216.htm   iXBRL 8-K 28355
2 EX-99.1 electionofthuntpressrelease.htm EX-99.1 11046
6 GRAPHIC imagea.jpg GRAPHIC 78528
  Complete submission text file 0001628280-24-052235.txt   277185

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blfs-20241216.xsd EX-101.SCH 1809
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blfs-20241216_lab.xml EX-101.LAB 22532
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blfs-20241216_pre.xml EX-101.PRE 13061
17 EXTRACTED XBRL INSTANCE DOCUMENT blfs-20241216_htm.xml XML 2719
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 241568416
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)